Third Harmonic Bio Inc (THRD)
13.33
-0.51
(-3.68%)
USD |
NASDAQ |
Jun 14, 16:00
13.31
-0.02
(-0.15%)
After-Hours: 20:00
Third Harmonic Bio Enterprise Value: 283.03M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 283.03M |
| June 13, 2024 | 303.92M |
| June 12, 2024 | 308.01M |
| June 11, 2024 | 309.24M |
| June 10, 2024 | 310.47M |
| June 07, 2024 | 319.07M |
| June 06, 2024 | 304.32M |
| June 05, 2024 | 299.82M |
| June 04, 2024 | 280.16M |
| June 03, 2024 | 292.86M |
| May 31, 2024 | 282.21M |
| May 30, 2024 | 296.13M |
| May 29, 2024 | 287.54M |
| May 28, 2024 | 296.54M |
| May 24, 2024 | 310.06M |
| May 23, 2024 | 309.24M |
| May 22, 2024 | 348.55M |
| May 21, 2024 | 373.53M |
| May 20, 2024 | 326.85M |
| May 17, 2024 | 304.94M |
| May 16, 2024 | 319.89M |
| May 15, 2024 | 266.24M |
| May 14, 2024 | 265.83M |
| May 13, 2024 | 231.02M |
| May 10, 2024 | 224.47M |
| Date | Value |
|---|---|
| May 09, 2024 | 240.85M |
| May 08, 2024 | 217.70M |
| May 07, 2024 | 223.40M |
| May 06, 2024 | 216.47M |
| May 03, 2024 | 214.03M |
| May 02, 2024 | 209.55M |
| May 01, 2024 | 200.99M |
| April 30, 2024 | 191.20M |
| April 29, 2024 | 191.61M |
| April 26, 2024 | 178.57M |
| April 25, 2024 | 163.49M |
| April 24, 2024 | 198.95M |
| April 23, 2024 | 187.54M |
| April 22, 2024 | 211.99M |
| April 19, 2024 | 213.21M |
| April 18, 2024 | 203.02M |
| April 17, 2024 | 196.91M |
| April 16, 2024 | 209.55M |
| April 15, 2024 | 217.70M |
| April 12, 2024 | 206.69M |
| April 11, 2024 | 225.44M |
| April 10, 2024 | 217.79M |
| April 09, 2024 | 183.18M |
| April 08, 2024 | 175.93M |
| April 05, 2024 | 167.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-137.34M
Minimum
Dec 20 2022
691.02M
Maximum
Sep 27 2022
87.53M
Average
-5.882M
Median
Enterprise Value Benchmarks
| AbbVie Inc | 353.68B |
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
| iBio Inc | 30.46M |
| Theriva Biologics Inc | -10.87M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.856M |
| Total Expenses (Quarterly) | 11.29M |
| EPS Diluted (Quarterly) | -0.20 |
| Earnings Yield | -5.63% |